3B Blackbio Dx Ltd.

3BBLACKBIONSEHealthcareMedical Equipment/Supplies/AccessoriesSmall Cap

₹1,196.1

▼ 0.42%

Composite

Kilpest India is one of India's leading agri-based companies. Kilpest is an ISO certified company and has representation in India in the field of agriculture business comprising crop protection products and public health products, bio products, micro-nutrients and mix fertilizers. The company has one of the most advance Research & Development facility at its Bhopal plant and also has Biological Research Centre. The products are manufactured to high international! BlS specifications with stringent quality control from raw material procurement to finished goods despatch.

www.kilpest.comSector: HealthcareIndustry: Medical Equipment/Supplies/Accessories

Q-DITS fundamental score

77Composite

Growth

100

Profitability

Valuation

Quality

Solvency

Earnings

Key metrics

MCap

₹1K Cr

TTM PE

17.6x

Industry PE

106x

TTM EPS

₹68.26

Book Value

₹315.77

Face Value

₹10

Div Yield

0.42%

PEG

0.57x

5.2x

ROE

19.4%

ROCE

26%

EBITDA mgn

67.6%

D/E

Int. Cover

590.8x

Curr. Ratio

7.11x

EPS

₹55.66

Growth — CAGR across horizons

Metric	1Y	3Y	5Y	10Y
Net Sales	47.1%	31.9%	-8.9%	23.4%
EBITDA	13.3%	24.9%	-17.7%	43.7%
Net Profit	23%	31%	-10.1%	67.6%

Score snapshot

Piotroski

9/9

Altman Z

2.15

Quality

90.3

Growth

100

Valuation

Earn. Qual

64.2

PEAD

SURGE

Revenue, profitability & returns

Revenue & Net Profit (₹ Cr)

RevenueNet Profit

Margins (%)

EBITDA%PAT%

Return ratios (%)

ROEROCEROA

Annual financials — last 10 years

Tap any row to see its trend

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	Trend
›RevenueCr	17	16	23	23	29	227	81	62	74	96	↑
›EBITDACr	2	3	6	8	11	153	44	36	46	65	↑
›EBITDA margin	8.6%	16.3%	24.4%	34.2%	37.8%	67.4%	54.6%	58.8%	61.4%	67.6%	↑
›Net profitCr	0	1	3	5	8	114	32	26	32	48	↑
›PAT margin	1.8%	6.5%	14.6%	22.5%	26.6%	50.2%	39.9%	41.9%	43.3%	49.4%	↑
›EPS₹	₹0.69	₹1.77	₹5.37	₹8.2	₹10.25	₹152	₹42.98	₹30.28	₹37.46	₹55.66	↑
›Revenue growth	-8.4%	-6.7%	43.6%	0.3%	24%	685.3%	-64.4%	-23.3%	19.9%	30.1%	↑
›PAT growth	43.5%	238%	202.7%	53%	46.7%	1,381.3%	-71.7%	-19.4%	23.8%	48.6%	↑
›ROE	3.3%	10.5%	27.6%	29%	28.2%	138.7%	22.6%	15%	15.4%	19.4%	↑
›ROCE	6.8%	12.5%	23.8%	28%	32.3%	179.5%	29.9%	20.2%	21.2%	26%	↑
›ROA	1.4%	4.6%	12.2%	15.7%	18.9%	95.5%	16.7%	12.8%	13.9%	17.5%	↑
›P/E	11.5x	19.4x	24.9x	9.2x	7.1x	1.9x	7.9x	13.7x	20.5x	29x	↑
›P/B	0.5x	2x	6.2x	2.1x	1.7x	1.6x	1.7x	1.8x	3x	5.2x	↑
›D/E	0.7	0.8	0.4	0.3	0.1	0	0	0	0	0	↓
›Current ratio	2x	2.1x	3x	3.1x	4.8x	2.8x	4.8x	8.1x	7x	7.1x	↑
›Interest cover	1.6x	2.4x	7.2x	16x	31.1x	666.8x	407.2x	179x	357.1x	590.8x	↑

Quarterly results

Tap any row to see its trend

Metric	2023-12	2024-03	2024-06	2024-09	2024-12	2025-03	2025-06	2025-09	2025-12	2026-03	Trend
›RevenueCr	18	23	19	29	25	22	22	34	50	35	↓
›Rev growth YoY	20%	27%	36.1%	52%	43.7%	-2.2%	14.4%	16.3%	98.3%	57.5%	↓
›EBITDACr	9	10	11	16	15	8	12	15	22	8	↓
›EBITDA margin	50.2%	43%	56.3%	55.5%	59.4%	35.2%	53.2%	43.5%	43.1%	24%	↓
›Net profitCr	9	9	11	15	13	8	13	15	22	10	↓
›PAT growth YoY	10.4%	69.1%	56.8%	95.9%	58.4%	-8.6%	11.9%	1.2%	66.3%	22%	↓
›EPS₹	₹10.18	₹10.35	₹12.99	₹17.1	₹15.64	₹9.8	₹14.69	₹17.17	₹25.36	₹11.15	↓

Balance sheet — last 10 years (₹ Cr)

Tap any row to see its trend

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	Trend
›Shareholders' equityCr	11	18	23	32	132	153	193	223	268	324	↑
›ReservesCr	5	7	16	25	125	146	185	214	260	316	↑
›Total borrowingsCr	0	0	0	0	0	0	0	0	0	0	—
›InvestmentsCr	0	0	0	1	70	104	92	117	156	0	↓
›Total assetsCr	14	21	25	36	149	173	197	226	271	378	↑
›Current assetsCr	22	26	32	39	118	82	114	123	132	193	↑
›Current liabilitiesCr	11	9	10	8	43	17	14	18	19	37	↑
›Trade payablesCr	4	3	4	3	3	4	3	4	2	7	↑
›Gross blockCr	7	8	8	9	11	12	14	14	15	28	↑

Cash flow statement (₹ Cr)

Tap any row to see its trend

Metric	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026	Trend
›Operating CF (CFO)Cr	1	2	4	7	98	37	20	27	43	52	↑
›Investing CF (CFI)Cr	-0	-1	-1	-1	-70	-28	15	-20	-34	-24	↑
›Financing CF (CFF)Cr	-0	0	-1	1	-2	-15	-5	-4	-3	-1	↑
›Net cash changeCr	0	1	2	7	26	-6	30	3	6	28	↑
›Closing cashCr	0	2	2	9	35	29	59	62	69	101	↑

Cash flow components

CFO · CFI · CFF (₹ Cr)

CFOCFICFF

Q-DITS scorecard

Composite score

Quality (25%)90.3

Growth (25%)100

Valuation (20%)27

Piotroski (15%)100

Earnings Quality (10%)64.2

Momentum (5%)—

Weighted blend, rescaled to the components available for this stock.

Piotroski F-Score

9/9

✓ROA positiveROA 17.54%

✓CFO positiveCFO ₹52.48 Cr

✓ROA improving13.89% → 17.54%

✓CFO > PAT (low accruals)CFO 52.48 vs PAT 47.69

✓Leverage decreasedD/E 0.0 → 0.0

✓Liquidity improvedCR 7.04 → 7.11

✓No share dilutionEPS 37.46 → 55.66

✓Margin improvedEBITDA mgn 61.4% → 67.58%

✓Asset turnover upAsset TO 0.32 → 0.35

Altman Z-Scoregrey

2.15

0.413

0.835

0.17

0.858

0.255

>2.9 safe · 1.23–2.9 grey · <1.23 distress

Quality

90.3/100

ROE

19.4%

ROCE

26%

Margin

49.4%

Debt

Int. cover

590.8x

Growth

100/100

Revenue 3Y

31.9%

Profit 3Y

31%

EPS

48.6%

Valuation

27/100

29.1x

5.2x

EV/EBITDA

20.2x

vs universe median: PE 23.47x · PB 2.95x · EV 14.02x

Earnings quality

64.2/100

CFO₹52 Cr

PAT₹48 Cr

Accrual ratio-0.013

CFO/PAT1.1x

PEAD · SURGE

0 / 0

Revenue SUE0.86

EPS SUE-0.79

Latest quarter2026-03

Rev growth YoY57.5%

Shareholding pattern

Promoter40.9%

FII/FPI2.6%

DII2%

Public59.1%

Tap any row to see its trend

Metric	2024-03	2024-06	2024-09	2024-12	2025-03	2025-06	2025-09	2025-12	2026-03	Trend
›Promoter	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	41.3%	40.9%	↓
›FII / FPI	3%	3.3%	3.3%	2.7%	2.5%	2.7%	2.6%	2.6%	2.6%	—
›DII	1.9%	2%	2%	1.7%	1.6%	1.8%	1.8%	1.9%	2%	↑
›Public / Retail	58.7%	58.7%	58.7%	58.7%	58.7%	58.7%	58.7%	58.7%	59.1%	↑
›Promoter pledge	0%	0%	0%	0%	0%	0%	0%	0%	0%	—

Documents & filings

Loading documents…

Peer comparison

Company	MCap (Cr)	Revenue	PAT	PE	PB	ROE%	ROCE%	D/E
Lenskart Solutions Ltd.	89,170	8,814	505	180.6x	10.2x	5.2	8.4	0.06
Poly Medicure Ltd.	15,838	1,875	315	49.2x	5.1x	16	20.4	0.06
Q-Line Biotech Ltd.	1,312	341	57	23x	—	13.9	19.2	0.88
Laxmi Dental Ltd.	1,229	278	26	42.4x	5.1x	21.4	25	0.06
Osel Devices Ltd.	814	293	29	27.8x	4.9x	30.1	31.1	0.46
Hemant Surgical Industries Ltd.	552	231	18	30.2x	3.8x	12.7	13.6	0.49
Prevest Denpro Ltd.	473	72	20	23.1x	3.8x	18.7	25.2	0